# FDA Inspection 1300470 - Matthew Brimberry, MD - January 30, 2026

Source: https://www.keypedia.com/records/fda_inspections/matthew-brimberry-md/bb43c471-e58c-49cc-9a4c-2413bd105e1f
Source feed: FDA_Inspections

> FDA Inspection 1300470 for Matthew Brimberry, MD on January 30, 2026. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1300470
- Company Name: Matthew Brimberry, MD
- Inspection Date: 2026-01-30
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Office Name: Dallas District Office

## Related Documents

- [FDA Inspection 1300470 - 2026-01-30](https://www.keypedia.com/records/fda_inspections/matthew-brimberry-md/14a099ea-dcef-45c1-a325-e46aeb138613)

Company: https://www.keypedia.com/companies/matthew-brimberry-md/9dadce12-ded2-45b1-a4d9-ed78ddc905fc

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9